- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02559999
Objective Markers of Pain Perception in Humans
October 22, 2018 updated by: Centre Hospitalier Universitaire de Saint Etienne
Objective Markers of Pain Perception in Humans: a Study in Healthy Subjects
Determine objective markers of pain perception remains a major scientific and medical issue.
Various tools have been proposed to objectify pain, but their adaptability to different clinical contexts are limited.
Our working hypothesis considers that the research for markers of immediate pain perception should be based on an electrophysiological approach, based on the combined analysis of EEG and autonomic responses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This project aims to study the cortical and autonomic responses induced by tonic painful stimulation compared to those induced by comparable sensory and stressful stimulations, by combining high density EEG, cutaneous sympathetic, cardiovascular and pupillary recordings.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lyon, France, 69500
- Hospices Civils de Lyon
-
Saint-etienne, France, 42000
- CHU DE SAINT-ETIENNE
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Affiliate or beneficiary of social security
- Signature of consent
Exclusion Criteria:
- History of cardiovascular disease (vagal syncope, hypertension, etc ...), renal, metabolic (diabetes ...), psychiatric (depression, etc ...) or neurological (seizure, etc ...) syndromes;
- Reynaud's syndrome;
- Raynaud's disease;
- Acrocyanosis;
- Known rhythm disorders;
- Participation at the same time in another clinical trial;
- Taking a medical treatment;
- Suffering from acute (complaint of pain in the week before the test) or chronic pain,
- Allergic to conductive gel for electrodes.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: EEG responses
The study compares electroencephalographical responses (EEG) to painful stimuli tonic to those evoked by non-painful stimuli and with or without virtual reality
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
EEG Gamma power.
Time Frame: Baseline
|
The EGG signals are compared between a painful stimuli tonic to those evoked by non-painful stimuli.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ratio of low to high frequency spectral powers
Time Frame: Baseline
|
The low and high frequency spectral powers are measured by an ECG Holter.
The ratio are compared between a painful stimuli tonic to those evoked by non-painful stimuli.
|
Baseline
|
Magnitude of the sympathetic cutaneous reactivity
Time Frame: Baseline
|
The sympathetic cutaneous reactivity is measured by an acquisition system (ME6000, MEDIMEX, France) with one electrode on the hand. The magnitudes are compared between a painful stimuli tonic to those evoked by non-painful stimuli. |
Baseline
|
Amplitude of pupillary dilation
Time Frame: Baseline
|
The pupillary dilation is measured by the ISCAN® system (MA, USA).
The amplitudes are compared between a painful stimuli tonic to those evoked by non-painful stimuli.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 4, 2014
Primary Completion (Actual)
February 28, 2018
Study Completion (Actual)
February 28, 2018
Study Registration Dates
First Submitted
September 24, 2015
First Submitted That Met QC Criteria
September 24, 2015
First Posted (Estimate)
September 25, 2015
Study Record Updates
Last Update Posted (Actual)
October 23, 2018
Last Update Submitted That Met QC Criteria
October 22, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1308172
- 2013-A01636-39 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Painful tonic stimuli
-
University of Maryland, BaltimorePurdue Pharma LPCompleted
-
Massimo InnamoratoUnknownFailed Back Surgery Syndrome
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
Leiden University Medical CenterCenter for Medical Systems Biology; Roba Metals BV, IJsselsteinCompletedAging | Calorie Restriction
-
Abbott Medical DevicesCompleted
-
University of BaselHorizon 2020 - European CommissionNot yet recruitingLight FlashingSwitzerland
-
IRCCS Burlo GarofoloRecruitingHearing Impaired ChildrenItaly
-
Centre Hospitalier Universitaire de Saint EtienneTerminated
-
Harvard Medical School (HMS and HSDM)Not yet recruiting